Testing the validity of the PDQ-39 in patients with MSA

Area of Science:

• Neurology
• Quality of Life Research

Background:

• The PDQ-39 is a quality of life instrument for Parkinson's disease.
• Multiple system atrophy (MSA) is a progressive neurodegenerative disorder.
• Assessing the validity of existing instruments in new patient populations is crucial.

Purpose of the Study:

• To evaluate the validity of the Parkinson's Disease Questionnaire (PDQ-39) in patients with multiple system atrophy (MSA).
• To determine if the PDQ-39 accurately reflects the quality of life in MSA patients.

Main Methods:

• 279 patients with MSA completed the PDQ-39, EQ-5D, Hospital Anxiety and Depression Scale, and other relevant scales.
• Statistical analyses included assessments for ceiling/floor effects, internal consistency, factor structure, and convergent/divergent validity.
• Higher order factor analysis was used to assess the suitability of a summary index.

Main Results:

• The PDQ-39 showed some ceiling and floor effects, with Mobility skewed towards severe symptoms.
• Most dimensions demonstrated high internal consistency, and the factor structure was stable in MSA.
• Convergent and divergent validity with other measures were good, but the PDQ-39 did not capture many MSA-specific features.

Conclusions:

• The PDQ-39 has limited validity for assessing quality of life in patients with multiple system atrophy.
• The instrument fails to adequately represent the unique clinical characteristics of MSA.
• A single summary index for the PDQ-39 is not supported in this patient group.